The severity of COVID-19 appears to be related to an exacerbated immune response and events associated with vascular injury1,3,10,11 Several studies have documented the association between COVID-19 severity and circulating levels of C-reactive protein (CRP), interleukin-6, and D-dimer12–16. The gene discussed is CRP; the disease is COVID-19.